Effects of dipyridamole and R-verapamil on in vitro proliferation of blast cells from patients with acute myelogenous leukaemia

This publication has 17 references indexed in Scilit:

• Can dipyridamole or verapamil slow regrowth of leukaemia cells?
  Leukemia Research, 1992
• Multidrug resistance (MDR 1) in leukemia: is it time to test? [editorial] [see comments]
  Blood, 1992
• Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis [see comments]
  Blood, 1992
• Effect of Dipyridamole, Theophyllamine and Verapamil on Spontaneous in Vitro Proliferation of Myelogenous Leukaemia Cells
  Acta Oncologica, 1992
• Some reasons for the lack of progress in the treatment of acute myelogenous leukemia: A review of three consecutive trials of the treatment of poor prognosis patients
  Leukemia Research, 1991
• Multidrug resistance: Clinical relevance in haematological malignancies
  Blood Reviews, 1991
• Tumor necrosis factor alpha stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulocyte/macrophage colony-stimulating factor.
  The Journal of Experimental Medicine, 1989
• Growth of clonogenic myeloblastic leukemic cells in the presence of human recombinant erythropoietin in addition to various human recombinant hematopoietic growth factors
  Blood, 1988
• Effects of verapamil on uptake and in vitro toxicity of anthracyclines in human leukemic blastcells
  European Journal of Haematology, 1988
• The effects of three recombinant growth factors, IL-3, GM-CSF, and G- CSF, on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture
  Blood, 1987